• Something wrong with this record ?

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group

JM. Neuberger, WO. Bechstein, DR. Kuypers, P. Burra, F. Citterio, S. De Geest, C. Duvoux, AG. Jardine, N. Kamar, BK. Krämer, HJ. Metselaar, F. Nevens, J. Pirenne, ML. Rodríguez-Perálvarez, D. Samuel, S. Schneeberger, D. Serón, P. Trunečka, G....

. 2017 ; 101 (4S Suppl 2) : S1-S56.

Language English Country United States

Document type Consensus Development Conference, Journal Article, Practice Guideline

Short-term patient and graft outcomes continue to improve after kidney and liver transplantation, with 1-year survival rates over 80%; however, improving longer-term outcomes remains a challenge. Improving the function of grafts and health of recipients would not only enhance quality and length of life, but would also reduce the need for retransplantation, and thus increase the number of organs available for transplant. The clinical transplant community needs to identify and manage those patient modifiable factors, to decrease the risk of graft failure, and improve longer-term outcomes.COMMIT was formed in 2015 and is composed of 20 leading kidney and liver transplant specialists from 9 countries across Europe. The group's remit is to provide expert guidance for the long-term management of kidney and liver transplant patients, with the aim of improving outcomes by minimizing modifiable risks associated with poor graft and patient survival posttransplant.The objective of this supplement is to provide specific, practical recommendations, through the discussion of current evidence and best practice, for the management of modifiable risks in those kidney and liver transplant patients who have survived the first postoperative year. In addition, the provision of a checklist increases the clinical utility and accessibility of these recommendations, by offering a systematic and efficient way to implement screening and monitoring of modifiable risks in the clinical setting.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023187
003      
CZ-PrNML
005      
20180103143406.0
007      
ta
008      
170720s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TP.0000000000001651 $2 doi
035    __
$a (PubMed)28328734
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Neuberger, James, $d 1949- $7 xx0219984 $u 1 Liver Unit, Queen Elizabeth Hospital Birmingham, United Kingdom. 2 Department of General and Visceral Surgery, Frankfurt University Hospital and Clinics, Germany. 3 Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Campus Gasthuisberg, Belgium. 4 Department of Surgery, Oncology, and Gastroenterology, Padova University Hospital, Padova, Italy. 5 Renal Transplantation Unit, Department of Surgical Science, Università Cattolica Sacro Cuore, Rome, Italy. 6 Department of Public Health, Faculty of Medicine, Institute of Nursing Science, University of Basel, Switzerland. 7 Department of Public Health, Faculty of Medicine, Centre for Health Services and Nursing Research, KU Leuven, Belgium. 8 Department of Hepatology and Liver Transplant Unit, Henri Mondor Hospital (AP-HP), Paris-Est University (UPEC), France. 9 Department of Nephrology, University of Glasgow, United Kingdom. 10 Department of Nephrology and Organ Transplantation, CHU Rangueil, Université Paul Sabatier, Toulouse, France. 11 Vth Department of Medicine & Renal Transplant Program, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany. 12 Department of Gastroenterology and Hepatology, Erasmus MC, University Hospital Rotterdam, the Netherlands. 13 Department of Gastroenterology and Hepatology, University Hospitals KU Leuven, Belgium. 14 Abdominal Transplant Surgery, Microbiology and Immunology Department, University Hospitals KU Leuven, Belgium. 15 Department of Hepatology and Liver Transplantation, Reina Sofía University Hospital, IMIBIC, CIBERehd, Spain. 16 Hepatobiliary Centre, Hospital Paul-Brousse (AP-HP), Paris-Sud University, Université Paris-Saclay, Villejuif, France. 17 Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Austria. 18 Nephrology Department, Hospital Vall d'Hebrón, Autonomous University of Barcelona, Spain. 19 Transplant Center, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic. 20 Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Italy. 21 Department of Hospital Pharmacy and Internal Medicine, Erasmus MC, the Netherlands.
245    10
$a Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group / $c JM. Neuberger, WO. Bechstein, DR. Kuypers, P. Burra, F. Citterio, S. De Geest, C. Duvoux, AG. Jardine, N. Kamar, BK. Krämer, HJ. Metselaar, F. Nevens, J. Pirenne, ML. Rodríguez-Perálvarez, D. Samuel, S. Schneeberger, D. Serón, P. Trunečka, G. Tisone, T. van Gelder,
520    9_
$a Short-term patient and graft outcomes continue to improve after kidney and liver transplantation, with 1-year survival rates over 80%; however, improving longer-term outcomes remains a challenge. Improving the function of grafts and health of recipients would not only enhance quality and length of life, but would also reduce the need for retransplantation, and thus increase the number of organs available for transplant. The clinical transplant community needs to identify and manage those patient modifiable factors, to decrease the risk of graft failure, and improve longer-term outcomes.COMMIT was formed in 2015 and is composed of 20 leading kidney and liver transplant specialists from 9 countries across Europe. The group's remit is to provide expert guidance for the long-term management of kidney and liver transplant patients, with the aim of improving outcomes by minimizing modifiable risks associated with poor graft and patient survival posttransplant.The objective of this supplement is to provide specific, practical recommendations, through the discussion of current evidence and best practice, for the management of modifiable risks in those kidney and liver transplant patients who have survived the first postoperative year. In addition, the provision of a checklist increases the clinical utility and accessibility of these recommendations, by offering a systematic and efficient way to implement screening and monitoring of modifiable risks in the clinical setting.
650    _2
$a následná péče $x metody $x normy $7 D000359
650    12
$a kontrolní seznam $7 D057189
650    _2
$a rejekce štěpu $x diagnóza $x etiologie $x mortalita $x prevence a kontrola $7 D006084
650    _2
$a přežívání štěpu $7 D006085
650    _2
$a lidé $7 D006801
650    _2
$a imunosupresiva $x škodlivé účinky $x terapeutické užití $7 D007166
650    12
$a transplantace ledvin $x mortalita $7 D016030
650    12
$a transplantace jater $x mortalita $7 D016031
650    _2
$a adherence k farmakoterapii $7 D055118
650    _2
$a oportunní infekce $x etiologie $x prevence a kontrola $7 D009894
650    _2
$a pooperační komplikace $x diagnóza $x etiologie $x mortalita $x prevence a kontrola $7 D011183
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
655    _2
$a konsensus - konference $7 D016446
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
700    1_
$a Bechstein, Wolf O
700    1_
$a Kuypers, Dirk R J
700    1_
$a Burra, Patrizia
700    1_
$a Citterio, Franco
700    1_
$a De Geest, Sabina
700    1_
$a Duvoux, Christophe
700    1_
$a Jardine, Alan G
700    1_
$a Kamar, Nassim
700    1_
$a Krämer, Bernhard K
700    1_
$a Metselaar, Herold J
700    1_
$a Nevens, Frederik
700    1_
$a Pirenne, Jacques
700    1_
$a Rodríguez-Perálvarez, Manuel L
700    1_
$a Samuel, Didier
700    1_
$a Schneeberger, Stefan
700    1_
$a Serón, Daniel
700    1_
$a Trunečka, Pavel
700    1_
$a Tisone, Giuseppe
700    1_
$a van Gelder, Teun
773    0_
$w MED00010695 $t Transplantation $x 1534-6080 $g Roč. 101, č. 4S Suppl 2 (2017), s. S1-S56
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28328734 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20180103143623 $b ABA008
999    __
$a ok $b bmc $g 1238868 $s 984100
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 101 $c 4S Suppl 2 $d S1-S56 $i 1534-6080 $m Transplantation $n Transplantation $x MED00010695
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...